| DC Field | Value | Language |
|---|
| dc.contributor.author | Bezhina, E. N. | - |
| dc.contributor.author | Alekhin, S. A. | - |
| dc.contributor.author | Artyushkova, E. B. | - |
| dc.contributor.author | Orlova, A. Y. | - |
| dc.contributor.author | Sernov, L. N. | - |
| dc.contributor.author | Denisuk, T. A. | - |
| dc.contributor.author | Peresypkina, A. A. | - |
| dc.date.accessioned | 2022-11-14T09:25:09Z | - |
| dc.date.available | 2022-11-14T09:25:09Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | Effect of L-norvaline on the small intestinal wall blood perfusion in a model of acute segmental mesenteric thrombosis / E.N. Bezhina [et al.] // Archivos Venezolanos de Farmacología y Terapéutica. - 2020. - Vol.39, №5.-P. 556-560. - Doi: 10.5281/zenodo.4266263. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/49584 | - |
| dc.description.abstract | The use of L-norvaline in the model of acute segmental mesenteric thrombosis with subsequent removal of blood clot has a significant protective effect leading to an increase of microcirculation blood velocity in the first minute of reperfusion with a decrease in the level of transient hyper- emia, and this protective action has a clear dose-dependent effect, which is maximally manifested in the dose range of 15-20 mg/kg | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | L-norvaline | ru |
| dc.subject | mesenteric thrombosis model | ru |
| dc.subject | intestinal ischemia | ru |
| dc.subject | reperfusion | ru |
| dc.title | Effect of L-norvaline on the small intestinal wall blood perfusion in a model of acute segmental mesenteric thrombosis | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
